share_log

內幕消息2024 年第一季度之未經審計最新資料

INSIDE INFORMATION UNAUDITED UPDATE ON THE 2024 FIRST QUARTER

Hong Kong Stock Exchange ·  May 16 06:01
Summary by Moomoo AI
京東健康股份有限公司（「京東健康」）公佈了2024年第一季度的未經審計財務數據。報告顯示，該季度京東健康的收入較去年同期下降了4.9%，為人民幣13,267,397千元；經營盈利下降了38.7%，為人民幣487,316千元；非國際財務報告準則經營盈利下降了34.8%，為人民幣754,380千元。公司強調，這些初步數據未經核數師審計或審閱，並可能會有所變動。在業務方面，京東健康在第一季度推出了多款新特藥，並上線了「養老頻道」，以滿足居家養老消費需求，同時強化了線上線下一體化的服務能力。公告由執行董事金恩林先生代表董事會於2024年5月16日發佈。
京東健康股份有限公司（「京東健康」）公佈了2024年第一季度的未經審計財務數據。報告顯示，該季度京東健康的收入較去年同期下降了4.9%，為人民幣13,267,397千元；經營盈利下降了38.7%，為人民幣487,316千元；非國際財務報告準則經營盈利下降了34.8%，為人民幣754,380千元。公司強調，這些初步數據未經核數師審計或審閱，並可能會有所變動。在業務方面，京東健康在第一季度推出了多款新特藥，並上線了「養老頻道」，以滿足居家養老消費需求，同時強化了線上線下一體化的服務能力。公告由執行董事金恩林先生代表董事會於2024年5月16日發佈。
KYOTO HEALTH CO., LTD. (“KYOTO HEALTH”) HAS ANNOUNCED UNAUDITED FINANCIAL DATA FOR THE FIRST QUARTER OF 2024. The report showed that in the quarter, revenue from Kyoto Health declined 4.9% compared to the same period last year to RMB13,267,397 thousand; operating profit fell 38.7% to RMB487,316 thousand; Non-International Financial Reporting Criteria operating profit fell 34.8% to RMB754,380 thousand. The company emphasizes that these preliminary data have not been audited or reviewed by auditors and are subject to change. In terms of business, Kyodo Health launched a number of new specialty drugs in the first quarter and launched a “retirement channel” to meet the needs of home nursing consumers, while strengthening its online and downstream integrated service capabilities. The announcement was made on 16 May 2024 by the Representative Board of Mr. Kim Enlin, Executive Director.
KYOTO HEALTH CO., LTD. (“KYOTO HEALTH”) HAS ANNOUNCED UNAUDITED FINANCIAL DATA FOR THE FIRST QUARTER OF 2024. The report showed that in the quarter, revenue from Kyoto Health declined 4.9% compared to the same period last year to RMB13,267,397 thousand; operating profit fell 38.7% to RMB487,316 thousand; Non-International Financial Reporting Criteria operating profit fell 34.8% to RMB754,380 thousand. The company emphasizes that these preliminary data have not been audited or reviewed by auditors and are subject to change. In terms of business, Kyodo Health launched a number of new specialty drugs in the first quarter and launched a “retirement channel” to meet the needs of home nursing consumers, while strengthening its online and downstream integrated service capabilities. The announcement was made on 16 May 2024 by the Representative Board of Mr. Kim Enlin, Executive Director.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more